217 related articles for article (PubMed ID: 10818145)
1. Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies.
Jenniskens GJ; Oosterhof A; Brandwijk R; Veerkamp JH; van Kuppevelt TH
J Neurosci; 2000 Jun; 20(11):4099-111. PubMed ID: 10818145
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporal distribution of heparan sulfate epitopes during myogenesis and synaptogenesis: a study in developing mouse intercostal muscle.
Jenniskens GJ; Hafmans T; Veerkamp JH; van Kuppevelt TH
Dev Dyn; 2002 Sep; 225(1):70-9. PubMed ID: 12203722
[TBL] [Abstract][Full Text] [Related]
3. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney.
van Kuppevelt TH; Dennissen MA; van Venrooij WJ; Hoet RM; Veerkamp JH
J Biol Chem; 1998 May; 273(21):12960-6. PubMed ID: 9582329
[TBL] [Abstract][Full Text] [Related]
4. Disturbed Ca2+ kinetics in N-deacetylase/N-sulfotransferase-1 defective myotubes.
Jenniskens GJ; Ringvall M; Koopman WJ; Ledin J; Kjellén L; Willems PH; Forsberg E; Veerkamp JH; van Kuppevelt TH
J Cell Sci; 2003 Jun; 116(Pt 11):2187-93. PubMed ID: 12692154
[TBL] [Abstract][Full Text] [Related]
5. Construction and evaluation of an antibody phage display library targeting heparan sulfate.
Damen LAA; van de Westerlo EMA; Versteeg EMM; van Wessel T; Daamen WF; van Kuppevelt TH
Glycoconj J; 2020 Aug; 37(4):445-455. PubMed ID: 32468289
[TBL] [Abstract][Full Text] [Related]
6. Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies.
Dennissen MA; Jenniskens GJ; Pieffers M; Versteeg EM; Petitou M; Veerkamp JH; van Kuppevelt TH
J Biol Chem; 2002 Mar; 277(13):10982-6. PubMed ID: 11790764
[TBL] [Abstract][Full Text] [Related]
7. Novel 'phage display antibodies identify distinct heparan sulfate domains in developing mammalian lung.
Thompson SM; Connell MG; Fernig DG; Ten Dam GB; van Kuppevelt TH; Turnbull JE; Jesudason EC; Losty PD
Pediatr Surg Int; 2007 May; 23(5):411-7. PubMed ID: 17216534
[TBL] [Abstract][Full Text] [Related]
8. Mouse mammary epithelial cells produce basement membrane and cell surface heparan sulfate proteoglycans containing distinct core proteins.
Jalkanen M; Rapraeger A; Bernfield M
J Cell Biol; 1988 Mar; 106(3):953-62. PubMed ID: 2964452
[TBL] [Abstract][Full Text] [Related]
9. Developmental changes in heparan sulfate expression: in situ detection with mAbs.
David G; Bai XM; Van der Schueren B; Cassiman JJ; Van den Berghe H
J Cell Biol; 1992 Nov; 119(4):961-75. PubMed ID: 1385449
[TBL] [Abstract][Full Text] [Related]
10. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease.
Su JH; Cummings BJ; Cotman CW
Neuroscience; 1992 Dec; 51(4):801-13. PubMed ID: 1488123
[TBL] [Abstract][Full Text] [Related]
11. Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes.
Faaber P; Rijke TP; van de Putte LB; Capel PJ; Berden JH
J Clin Invest; 1986 Jun; 77(6):1824-30. PubMed ID: 2940265
[TBL] [Abstract][Full Text] [Related]
12. A mutant-cell library for systematic analysis of heparan sulfate structure-function relationships.
Qiu H; Shi S; Yue J; Xin M; Nairn AV; Lin L; Liu X; Li G; Archer-Hartmann SA; Dela Rosa M; Galizzi M; Wang S; Zhang F; Azadi P; van Kuppevelt TH; Cardoso WV; Kimata K; Ai X; Moremen KW; Esko JD; Linhardt RJ; Wang L
Nat Methods; 2018 Nov; 15(11):889-899. PubMed ID: 30377379
[TBL] [Abstract][Full Text] [Related]
13. A syngeneic monoclonal antibody to murine Meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): cell density and transformation dependent alteration in cell surface HS-GAG defined by HepSS-1.
Kure S; Yoshie O
J Immunol; 1986 Dec; 137(12):3900-8. PubMed ID: 2431047
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate phage display antibodies recognise epitopes defined by a combination of sugar sequence and cation binding.
Solari V; Rudd TR; Guimond SE; Powell AK; Turnbull JE; Yates EA
Org Biomol Chem; 2015 Jun; 13(21):6066-72. PubMed ID: 25952831
[TBL] [Abstract][Full Text] [Related]
15. Novel heparan sulfate structures revealed by monoclonal antibodies.
van den Born J; Salmivirta K; Henttinen T; Ostman N; Ishimaru T; Miyaura S; Yoshida K; Salmivirta M
J Biol Chem; 2005 May; 280(21):20516-23. PubMed ID: 15778504
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic knock out of heparan sulfates in myotubes impairs excitation-induced calcium spiking.
Jenniskens GJ; Koopman WJ; Willems PH; Pecker I; Veerkamp JH; van Kuppevelt TH
FASEB J; 2003 May; 17(8):878-80. PubMed ID: 12626439
[TBL] [Abstract][Full Text] [Related]
17. A synthetic glycosaminoglycan mimetic (RGTA) modifies natural glycosaminoglycan species during myogenesis.
Barbosa I; Morin C; Garcia S; Duchesnay A; Oudghir M; Jenniskens G; Miao HQ; Guimond S; Carpentier G; Cebrian J; Caruelle JP; van Kuppevelt T; Turnbull J; Martelly I; Papy-Garcia D
J Cell Sci; 2005 Jan; 118(Pt 1):253-64. PubMed ID: 15615789
[TBL] [Abstract][Full Text] [Related]
18. Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities.
Thompson SM; Fernig DG; Jesudason EC; Losty PD; van de Westerlo EM; van Kuppevelt TH; Turnbull JE
J Biol Chem; 2009 Dec; 284(51):35621-31. PubMed ID: 19837661
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulfate proteoglycans from mouse mammary epithelial cells: localization on the cell surface with a monoclonal antibody.
Jalkanen M; Nguyen H; Rapraeger A; Kurn N; Bernfield M
J Cell Biol; 1985 Sep; 101(3):976-84. PubMed ID: 3161899
[TBL] [Abstract][Full Text] [Related]
20. Phage display-derived human antibodies against specific glycosaminoglycan epitopes.
Smits NC; Lensen JF; Wijnhoven TJ; Ten Dam GB; Jenniskens GJ; van Kuppevelt TH
Methods Enzymol; 2006; 416():61-87. PubMed ID: 17113860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
